None listed
Conditions
Interventions
Intervention1: IP1 - Okra extract + Placebo: Abelmoschus Esculentus extract (okra) 500 mg + Placebo ( Wheat powder 100%) 500mg for 30 days.
Intervention2: IP2 - Okra extract: Abelmoschus Esculentus e
Sponsors
Arjuna Natural Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Males and Females 25 to 40 years of age (1:1 ratio) Body Mass Index between from 18.5 to 24.9 kg/m2 Being recreationally active ââ?¬â?? Habitual running for 30 min for at least 3 days in a week for the past 3 months. IPAQ vigorous activity not less than 720 MET minutes per week. Normotensive (seated, resting systolic blood pressure less than 140 mm Hg and diastolic blood pressure less than 90 mm Hg. Normal seated, resting heart rate (less than 90 beats per minute). Subjects who are willing to refrain from using protein, vitamin, mineral and herbal supplements for the study period. Ability to follow all instructions in the study protocol and be willing to give written informed consent.
Exclusion criteria
Exclusion criteria: COVID positive in the past 6 months. Received any vaccinations in the past 6 months. Current use of prescription or over-the-counter medications or unwillingness or inability to discontinue use of these medications at least 4 weeks before beginning the study. Cardiovascular complications. Use of protein, vitamin, mineral, and herbal supplements 1 week before the study. Alcoholic (greater than 2 pegs(60ml)per day) and smoking (has not stopped within 3 months of the study) Medical problems that would be a direct physical limitation. Current treatment for depression, alcohol or substance abuse, or psychosis Women of childbearing age intending for pregnancy or are pregnant, breastfeeding, or willing to practice contraception. Any condition, including laboratory abnormalities, that in the opinion of investigator places the volunteer at an unacceptable risk or deems the volunteer not suitable for participation in the study. Subjects who are unwilling to abstain from consuming okra and any other dietary supplements and to maintain their normal training and dietary habits. Subjects who participated in a clinical trial for the past 3 months. Unwilling to provide written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean change in the total distance covered on treadmill in the 15 min timed test.Timepoint: Day4 and Day34 | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean change in peak power output in the vertical jump testTimepoint: Day4 & Day34.;Mean change in time to exhaustion in the Barbell lift & hold testTimepoint: Day4 & Day34.;Mean change in Borg 6-20 RPE scaleTimepoint: Day4 & Day34;Mean change in the mean score of FSS, & VAS-FTimepoint: Day4 & Day34;Mean change in biomarkersTimepoint: from D4 to D34 | — |
Countries
India
Contacts
Public ContactSooraj Rajasekharan Kartha
Arjuna Natural Pvt Ltd
Outcome results
None listed